Andrew J. Greenfield - Sep 30, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role: VP, Chief Commercial Officer
Signature: /s/ Marc A. Began (by power of attorney)
Stock symbol: ABMD
Transactions as of: Sep 30, 2021
Transactions value $: $0
Form type: 4
Date filed: 10/4/2021, 05:19 PM
Previous filing: Jun 2, 2021
Next filing: Nov 5, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABMD	Common Stock, $.01 par value	Award	$0	+26	+0.07%	$0.00	37.8K	Sep 30, 2021	Direct	F3
holding	ABMD	Common Stock, $.01 par value						12K	Sep 30, 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ABMD	Stock Option (right to buy)						5K	Sep 30, 2021	Common Stock	0	$99.62	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						6.5K	Sep 30, 2021	Common Stock	0	$134.51	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						4K	Sep 30, 2021	Common Stock	0	$381.97	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						7K	Sep 30, 2021	Common Stock	0	$266.39	Direct	F1, F2
holding	ABMD	Stock Option (right to buy						4.9K	Sep 30, 2021	Common Stock	0	$223.90	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						2.87K	Sep 30, 2021	Common Stock	0	$283.88	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F2	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F3	These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).